Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin condition that manifests as painful, deep-seated, inflamed nodules and abscesses in the axillary, groin, perianal, perineal, and inframammary regions. The associated pain, malodour, and disfigurement contribute to its profound...
Gespeichert in:
| Veröffentlicht in: | Paediatric drugs 2023-11, Vol.25 (6), p.659-676 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 676 |
|---|---|
| container_issue | 6 |
| container_start_page | 659 |
| container_title | Paediatric drugs |
| container_volume | 25 |
| creator | Chiang, Nicholas Sibbald, Cathryn Levy, Rebecca Lara-Corrales, Irene |
| description | Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin condition that manifests as painful, deep-seated, inflamed nodules and abscesses in the axillary, groin, perianal, perineal, and inframammary regions. The associated pain, malodour, and disfigurement contribute to its profound negative impact on psychosocial spheres and overall quality of life in affected individuals. Although the symptoms of HS classically begin in the second or third decade of life, HS affects children and adolescents as well. Despite this, there are limited pediatric data on treatment, which are largely based on expert opinion, extrapolation of efficacy data in adults with HS, and safety information from medication use in other pediatric diseases. On this basis, there exist several pharmacological modalities in the treatment of children and adolescents with HS including topical therapies, systemic therapies, and biologics. The goals of this review article are to: (1) review the efficacy of different pharmacological treatment modalities in children and adolescents with HS, and (2) review the safety and monitoring considerations of the different treatment options in children and adolescents with HS. |
| doi_str_mv | 10.1007/s40272-023-00595-6 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2884351667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A770320506</galeid><sourcerecordid>A770320506</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-d800b86eb57f168096d51b9a70a0d2ead0a9791b7f05027c330dd7d89fabd4053</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoso-PkHPAU8VydJ26TelkVdYUFB9xymTbpG2qQmqeC_t-sK3jzNHJ53Pp4su6RwTQHETSyACZYD4zlAWZd5dZCdUCrqnAGtD3_6Ii-lkMfZaYzvAFTwip1kzcrqgNo4m2wkL9M4TgGT_URiHVm-2V4H4wg6TRba9ya2xqV4SxaObEaNyRDvyPMbhgFb3_utbclrMJiGGSNPY7LexfPsqMM-movfepZt7u9el6t8_fTwuFys85ZLSLmWAI2sTFOKjlYS6kqXtKlRAIJmBjVgLWraiA7K-dmWc9BaaFl32OgCSn6WXe3njsF_TCYm9e6n4OaViklZ8JJWlfijttgbZV3nU8B2sLFVCyGAs3l6NVNsT7XBxxhMp8ZgBwxfioLaGVd742o2rn6Mq12I70Nxht3WhL8D_kl9A2wuguw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2884351667</pqid></control><display><type>article</type><title>Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options</title><source>SpringerLink Journals</source><creator>Chiang, Nicholas ; Sibbald, Cathryn ; Levy, Rebecca ; Lara-Corrales, Irene</creator><creatorcontrib>Chiang, Nicholas ; Sibbald, Cathryn ; Levy, Rebecca ; Lara-Corrales, Irene</creatorcontrib><description>Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin condition that manifests as painful, deep-seated, inflamed nodules and abscesses in the axillary, groin, perianal, perineal, and inframammary regions. The associated pain, malodour, and disfigurement contribute to its profound negative impact on psychosocial spheres and overall quality of life in affected individuals. Although the symptoms of HS classically begin in the second or third decade of life, HS affects children and adolescents as well. Despite this, there are limited pediatric data on treatment, which are largely based on expert opinion, extrapolation of efficacy data in adults with HS, and safety information from medication use in other pediatric diseases. On this basis, there exist several pharmacological modalities in the treatment of children and adolescents with HS including topical therapies, systemic therapies, and biologics. The goals of this review article are to: (1) review the efficacy of different pharmacological treatment modalities in children and adolescents with HS, and (2) review the safety and monitoring considerations of the different treatment options in children and adolescents with HS.</description><identifier>ISSN: 1174-5878</identifier><identifier>EISSN: 1179-2019</identifier><identifier>DOI: 10.1007/s40272-023-00595-6</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abscesses ; Acne ; Adults ; Arthritis ; Children ; Comorbidity ; Dermatologic agents ; Dermatology ; Disease ; Diseases ; Drug therapy ; Formulae, receipts, prescriptions ; Internal Medicine ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Obesity ; Pediatric research ; Pediatrics ; Pharmacotherapy ; Quality of life ; Review Article ; Skin ; Skin diseases ; Smoking cessation ; Teenagers ; Topical medication ; Weight control</subject><ispartof>Paediatric drugs, 2023-11, Vol.25 (6), p.659-676</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>COPYRIGHT 2023 Springer</rights><rights>Copyright Springer Nature B.V. Nov 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-d800b86eb57f168096d51b9a70a0d2ead0a9791b7f05027c330dd7d89fabd4053</citedby><cites>FETCH-LOGICAL-c380t-d800b86eb57f168096d51b9a70a0d2ead0a9791b7f05027c330dd7d89fabd4053</cites><orcidid>0000-0002-3210-3413 ; 0000-0001-9288-1121 ; 0000-0002-9488-9917 ; 0000-0002-5407-3972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40272-023-00595-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40272-023-00595-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids></links><search><creatorcontrib>Chiang, Nicholas</creatorcontrib><creatorcontrib>Sibbald, Cathryn</creatorcontrib><creatorcontrib>Levy, Rebecca</creatorcontrib><creatorcontrib>Lara-Corrales, Irene</creatorcontrib><title>Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options</title><title>Paediatric drugs</title><addtitle>Pediatr Drugs</addtitle><description>Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin condition that manifests as painful, deep-seated, inflamed nodules and abscesses in the axillary, groin, perianal, perineal, and inframammary regions. The associated pain, malodour, and disfigurement contribute to its profound negative impact on psychosocial spheres and overall quality of life in affected individuals. Although the symptoms of HS classically begin in the second or third decade of life, HS affects children and adolescents as well. Despite this, there are limited pediatric data on treatment, which are largely based on expert opinion, extrapolation of efficacy data in adults with HS, and safety information from medication use in other pediatric diseases. On this basis, there exist several pharmacological modalities in the treatment of children and adolescents with HS including topical therapies, systemic therapies, and biologics. The goals of this review article are to: (1) review the efficacy of different pharmacological treatment modalities in children and adolescents with HS, and (2) review the safety and monitoring considerations of the different treatment options in children and adolescents with HS.</description><subject>Abscesses</subject><subject>Acne</subject><subject>Adults</subject><subject>Arthritis</subject><subject>Children</subject><subject>Comorbidity</subject><subject>Dermatologic agents</subject><subject>Dermatology</subject><subject>Disease</subject><subject>Diseases</subject><subject>Drug therapy</subject><subject>Formulae, receipts, prescriptions</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Obesity</subject><subject>Pediatric research</subject><subject>Pediatrics</subject><subject>Pharmacotherapy</subject><subject>Quality of life</subject><subject>Review Article</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>Smoking cessation</subject><subject>Teenagers</subject><subject>Topical medication</subject><subject>Weight control</subject><issn>1174-5878</issn><issn>1179-2019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE1LxDAQhoso-PkHPAU8VydJ26TelkVdYUFB9xymTbpG2qQmqeC_t-sK3jzNHJ53Pp4su6RwTQHETSyACZYD4zlAWZd5dZCdUCrqnAGtD3_6Ii-lkMfZaYzvAFTwip1kzcrqgNo4m2wkL9M4TgGT_URiHVm-2V4H4wg6TRba9ya2xqV4SxaObEaNyRDvyPMbhgFb3_utbclrMJiGGSNPY7LexfPsqMM-movfepZt7u9el6t8_fTwuFys85ZLSLmWAI2sTFOKjlYS6kqXtKlRAIJmBjVgLWraiA7K-dmWc9BaaFl32OgCSn6WXe3njsF_TCYm9e6n4OaViklZ8JJWlfijttgbZV3nU8B2sLFVCyGAs3l6NVNsT7XBxxhMp8ZgBwxfioLaGVd742o2rn6Mq12I70Nxht3WhL8D_kl9A2wuguw</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Chiang, Nicholas</creator><creator>Sibbald, Cathryn</creator><creator>Levy, Rebecca</creator><creator>Lara-Corrales, Irene</creator><general>Springer International Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><orcidid>https://orcid.org/0000-0002-3210-3413</orcidid><orcidid>https://orcid.org/0000-0001-9288-1121</orcidid><orcidid>https://orcid.org/0000-0002-9488-9917</orcidid><orcidid>https://orcid.org/0000-0002-5407-3972</orcidid></search><sort><creationdate>20231101</creationdate><title>Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options</title><author>Chiang, Nicholas ; Sibbald, Cathryn ; Levy, Rebecca ; Lara-Corrales, Irene</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-d800b86eb57f168096d51b9a70a0d2ead0a9791b7f05027c330dd7d89fabd4053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abscesses</topic><topic>Acne</topic><topic>Adults</topic><topic>Arthritis</topic><topic>Children</topic><topic>Comorbidity</topic><topic>Dermatologic agents</topic><topic>Dermatology</topic><topic>Disease</topic><topic>Diseases</topic><topic>Drug therapy</topic><topic>Formulae, receipts, prescriptions</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Obesity</topic><topic>Pediatric research</topic><topic>Pediatrics</topic><topic>Pharmacotherapy</topic><topic>Quality of life</topic><topic>Review Article</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>Smoking cessation</topic><topic>Teenagers</topic><topic>Topical medication</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiang, Nicholas</creatorcontrib><creatorcontrib>Sibbald, Cathryn</creatorcontrib><creatorcontrib>Levy, Rebecca</creatorcontrib><creatorcontrib>Lara-Corrales, Irene</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Paediatric drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiang, Nicholas</au><au>Sibbald, Cathryn</au><au>Levy, Rebecca</au><au>Lara-Corrales, Irene</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options</atitle><jtitle>Paediatric drugs</jtitle><stitle>Pediatr Drugs</stitle><date>2023-11-01</date><risdate>2023</risdate><volume>25</volume><issue>6</issue><spage>659</spage><epage>676</epage><pages>659-676</pages><issn>1174-5878</issn><eissn>1179-2019</eissn><abstract>Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin condition that manifests as painful, deep-seated, inflamed nodules and abscesses in the axillary, groin, perianal, perineal, and inframammary regions. The associated pain, malodour, and disfigurement contribute to its profound negative impact on psychosocial spheres and overall quality of life in affected individuals. Although the symptoms of HS classically begin in the second or third decade of life, HS affects children and adolescents as well. Despite this, there are limited pediatric data on treatment, which are largely based on expert opinion, extrapolation of efficacy data in adults with HS, and safety information from medication use in other pediatric diseases. On this basis, there exist several pharmacological modalities in the treatment of children and adolescents with HS including topical therapies, systemic therapies, and biologics. The goals of this review article are to: (1) review the efficacy of different pharmacological treatment modalities in children and adolescents with HS, and (2) review the safety and monitoring considerations of the different treatment options in children and adolescents with HS.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1007/s40272-023-00595-6</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-3210-3413</orcidid><orcidid>https://orcid.org/0000-0001-9288-1121</orcidid><orcidid>https://orcid.org/0000-0002-9488-9917</orcidid><orcidid>https://orcid.org/0000-0002-5407-3972</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1174-5878 |
| ispartof | Paediatric drugs, 2023-11, Vol.25 (6), p.659-676 |
| issn | 1174-5878 1179-2019 |
| language | eng |
| recordid | cdi_proquest_journals_2884351667 |
| source | SpringerLink Journals |
| subjects | Abscesses Acne Adults Arthritis Children Comorbidity Dermatologic agents Dermatology Disease Diseases Drug therapy Formulae, receipts, prescriptions Internal Medicine Medicine Medicine & Public Health Monoclonal antibodies Obesity Pediatric research Pediatrics Pharmacotherapy Quality of life Review Article Skin Skin diseases Smoking cessation Teenagers Topical medication Weight control |
| title | Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T00%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hidradenitis%20Suppurativa%20in%20Children%20and%20Adolescents:%20An%20Update%20on%20Pharmacologic%20Treatment%20Options&rft.jtitle=Paediatric%20drugs&rft.au=Chiang,%20Nicholas&rft.date=2023-11-01&rft.volume=25&rft.issue=6&rft.spage=659&rft.epage=676&rft.pages=659-676&rft.issn=1174-5878&rft.eissn=1179-2019&rft_id=info:doi/10.1007/s40272-023-00595-6&rft_dat=%3Cgale_proqu%3EA770320506%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2884351667&rft_id=info:pmid/&rft_galeid=A770320506&rfr_iscdi=true |